Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban vs Warfarin in Atrial Fibrillation
NCT00781391Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Nov 2008
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 46
01
Overview
A Phase 3 trial of edoxaban in Atrial fibrillation (AFib), sponsored by Daiichi Sankyo Co., Ltd.. Started Nov 2008; status: completed.
02
Drugs
edoxaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00781391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00781391.